Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolios

Proxy firm Glass Lewis backs NextGen's slate in proxy contest

Published 10/05/2021, 09:25 AM
Updated 10/05/2021, 10:00 AM
© Reuters.
NXGN
-

NEW YORK (Reuters) - Glass Lewis & Co recommended that NextGen Healthcare (NASDAQ:NXGN) Inc shareholders elect management's slate of directors, becoming the second prominent proxy advisory firm to support the board and management over the company's founder, Sheldon Razin.

"Given the circumstances, we believe shareholders will likely be best served supporting the board’s current slate, one that already reflects a significant refreshment that includes the Company’s recently-hired CEO and three other brand new nominees," the Glass Lewis report, issued this week, said.

Last week, Institutional Shareholder Services also recommended that NextGen Healthcare Inc shareholders elect management's four board nominees.

Glass Lewis and ISS both recommend that shareholders eliminate cumulative voting and reincorporate the company in Delaware.

Razin, who has served on the board since 1974, has nominated four directors and has criticized the company's poor financial returns. Shareholders will vote on Oct. 13.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.